The association between paternal prostate cancer and type 2 diabetes

Journal of Carcinogenesis

Volumn 6, Issue , 2007, Pages

  Meyer, Peter ^a,b   Zuern, Christine ^b   Hermanns, Norbert ^c   Haak, Thomas ^c  

^a Institute of Molecular Medicine   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Res Inst of the Diabetes Academy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILIARY TRACT CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HEREDITY; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PROSTATE CANCER; RISK ASSESSMENT; STOMACH CANCER; UTERINE CERVIX CANCER;

EID: 35648969486     PISSN: None     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-6-14     Document Type: Article

References (25)

1. Chow WH Gridley G Nyren O Linet MS Ekbom A Fraumeni JF Jr Adami HO Risk of pancreatic cancer following diabetes mellitus: A nationwide cohort study in Sweden J Natl Cancer Inst 1995, 87:930-931 10.1093/jnci/ 87.12.930 7666483
2. Everhart J Wright D Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis JAMA 1995, 273:1605-1609 10.1001/ jama.273.20.1605 7745774
3. Hu FB Manson JE Liu S Hunter D Colditz GA Michels KB Speizer FE Giovannucci E Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women J Natl Cancer Inst 1999, 91:542-547 10.1093/jnci/91.6.542 10088625
4. Adami HO McLaughlin J Ekbom A Berne C Silverman D Hacker D Persson I Cancer risk in patients with diabetes mellitus Cancer Causes Control 1991, 2:307-314 10.1007/BF00051670 1932543
5. La Vecchia C Negri E Franceschi S D'Avanzo B Boyle P A case-control study of diabetes mellitus and cancer risk Br J Cancer 1994, 70:950-953 7947103
6. Weiderpass E Gridley G Persson I Nyren O Ekbom A Adami HO Risk of endometrial and breast cancer in patients with diabetes mellitus Int J Cancer 1997, 71:360-363 10.1002/ (SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W 9139868
7. Wideroff L Gridley G Mellemkjaer L Chow WH Linet M Keehn S Borch-Johnsen K Olsen JH Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark J Natl Cancer Inst 1997, 89:1360-1365 10.1093/jnci/89.18.1360 9308706
8. Adami HO Chow WH Nyren O Berne C Linet MS Ekbom A Wolk A McLaughlin JK Fraumeni JF Jr Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 1996, 88:1472-1477 10.1093/jnci/ 88.20.1472 8841022
9. Lagergren J Bergstrom R Nyren O Association between body mass and adenocarcinoma of the esophagus and gastric cardia Ann Intern Med 1999, 130:883-890 10375336
10. Steenland K Nowlin S Palu S Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: Diabetes, cholesterol, pulse and physical activity Cancer Epidemiol Biomarkers Prev 1995, 4:807-811 8634649
11. Coughlin SS Neaton JD Sengupta A Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial Am J Epidemiol 1996, 143:1002-1006 8629606
12. Giovannucci E Rimm EB Stampfer MJ Colditz GA Willett WC Diabetes mellitus and risk of prostate cancer (United States) Cancer Causes Control 1998, 9:3-9 10.1023/A:1008822917449 9486458
13. Tavani A Gallus S Bosetti C Tzonou A Lagiou P Negri E Trichopoulos D La Vecchia C Diabetes and the risk of prostate cancer Eur J Cancer Prev 2002, 11:125-128 10.1097/00008469-200204000-00003 11984129
14. Weiderpass E Ye W Vainio H Kaaks R Adami HO Reduced risk of prostate cancer among patients with diabetes mellitus Int J Cancer 2002, 102:258-261 10.1002/ijc.10685 12397646
15. Rosenberg DJ Neugut AI Ahsan H Shea S Diabetes mellitus and the risk of prostate cancer Cancer Invest 2002, 20:157-165 10.1081/CNV-120001141 11901534
16. Mantzoros CS Tzonou A Signorello LB Stampfer M Trichopoulos D Adami HO Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia Br J Cancer 1997, 76:1115-1118 9365156
17. Kaaks R Lukanova A Energy balance and cancer: The role of insulin and insulin-like growth factor-I Proc Nutr Soc 2001, 60:91-106 11310428
18. Chan JM Stampfer MJ Giovannucci E Gann PH Ma J Wilkinson P Hennekens CH Pollak M Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study Science 1998, 279:563-566 10.1126/science.279.5350.563 9438850
19. Pollak M Insulin-like growth factors and prostate cancer Epidemiol Rev 2001, 23:59-66 11588855
20. Kaaks R Lukanova A Sommersberg B Plasma androgens, IGF-1, body size, and prostate cancer risk: A synthetic review Prostate Cancer Prostatic Dis 2000, 3:157-172 10.1038/sj.pcan.4500421 12497092
21. Bosland MC The role of steroid hormones in prostate carcinogenesis J Natl Cancer Inst Monogr 2000:39-66 10963619
22. Chokkalingam AP Pollak M Fillmore CM Gao YT Stanczyk FZ Deng J Sesterhenn IA Mostofi FK Fears TR Madigan MP Ziegler RG Fraumeni JF Jr Hsing AW Insulin-like growth factors and prostate cancer: A population-based case-control study in China Cancer Epidemiol Biomarkers Prev 2001, 10:421-427 11352850
23. Altshuler D Hirschhorn JN Klannemark M Lindgren CM Vohl MC Nemesh J Lane CR Schaffner SF Bolk S Brewer C Tuomi T Gaudet D Hudson TJ Daly M Groop L Lander ES The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nat Genet 2000, 26:76-80 10.1038/ 79839 10973253
24. Hegele RA Cao H Harris SB Zinman B Hanley AJ Anderson CM Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree J Clin Endocrinol Metab 2000, 85:2014-2019 10.1210/ jc.85.5.2014 10843190
25. Mueller E Smith M Sarraf P Kroll T Aiyer A Kaufman DS Oh W Demetri G Figg WD Zhou XP Eng C Spiegelman BM Kantoff PW Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer Proc Natl Acad Sci USA 2000, 97:10990-10995 27136 10984506 10.1073/pnas.180329197